LS-008

N/A

Report date: 2026/02/05 09:22:46
NME

Base Information

Drug NameLS-008
Drug Alias NameLS-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 inhibitorsPI3-kinase class I inhibitors
TargetsPolo like kinase 1PI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChangzhou Lesun Pharmaceutical LtdGuizhou Xi'Erkang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuizhou Xi'Erkang Pharmaceutical Co LtdChangzhou Lesun Pharmaceutical Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A